Four Obstacles to Technology Transfer

{WantNoCacheVal} Four Obstacles to Technology Transfer Washington--Limited oppotunities for proprietary research, an inability to copyright and license software and institutional red tape are major obstacles in transferring technology from federal laboratories to U.S. industry according to a new report from the General Accounting Office. The report examined 10 laboratories operated by six government agencies, raging from the Air Force’s Lincoln Laboratory to the National Institutes of H

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Washington--Limited oppotunities for proprietary research, an inability to copyright and license software and institutional red tape are major obstacles in transferring technology from federal laboratories to U.S. industry according to a new report from the General Accounting Office.

The report examined 10 laboratories operated by six government agencies, raging from the Air Force’s Lincoln Laboratory to the National Institutes of Health. Interviews with lab officials found that a majority support regulatory changes that would encourage businesses to invest in cooperative research within the labs and to make use of products produced by its scientists.

The report, carried out at the request of the Task Force on Technology Policy of the House Committee on Science, Space and Technology, suggested that computer software be treated similarly to other federal inventions and that companies allowed to treat the results of collaborative research as trade secrets for up to five years, It also suggested ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies